Last 12 months
Inside the activity.
0 purchase rows · 15 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 6 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 14, 2020 Filed Dec 15, 2020 22:27 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
PurchaseOrdinary Shares | 10,000 | $18.50 | $185,000.00 |
DisclosureSEC source: 0001209191-20-063558 · doc4.xml · nonDerivative · entry 1 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,117 Read SEC document |
| December 04, 2020 Filed Dec 4, 2020 21:35 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 61,652 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-061812 · doc4.xml · derivative · entry 2 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,496 Underlying: Ordinary Shares · 61,652 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on January 3, 2019 representing 317,065 ordinary shares. 33.33% of the RSUs vested on January 3, 2020. The remaining unvested restricted stock units will vest at a rate of 2.778% in equal monthly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on January 3, 2019 representing 317,065 ordinary shares. 33.33% of the RSUs vested on January 3, 2020. The remaining unvested restricted stock units will vest at a rate of 2.778% in equal monthly installments thereafter. Read SEC document |
| December 04, 2020 Filed Dec 4, 2020 21:35 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 61,652 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-061812 · doc4.xml · nonDerivative · entry 1 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the settlement of restricted stock units that vested from June 3, 2020 through December 3, 2020 through the issuance of ordinary shares. Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 20:59 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-061921 · doc4.xml · derivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,042 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on December 7, 2017 representing 12,500 ordinary shares. 33.33% of the RSUs vested on December 4, 2018 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on December 7, 2017 representing 12,500 ordinary shares. 33.33% of the RSUs vested on December 4, 2018 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 20:59 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 662 | $19.85 | $13,140.70 |
DisclosureSEC source: 0001209191-20-061921 · doc4.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,723 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 20:59 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 1,042 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-061921 · doc4.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,385 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| December 03, 2020 Filed Jul 12, 2021 22:59 UTC Amendment |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,808 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-046344 · doc4a.xml · derivative · entry 14 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,496 Underlying: Ordinary Shares · 8,808 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F1 · date: On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020. In fact, the shares vested monthly from June 3, 2020. F3 · derivative.exercise_date: On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years. F3 · derivative.expiration_date: On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years. Read SEC document |
| December 03, 2020 Filed Jul 12, 2021 22:59 UTC Amendment |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 8,808 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-046344 · doc4a.xml · nonDerivative · entry 7 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020. In fact, the shares vested monthly from June 3, 2020. F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 03, 2020 Filed Jul 12, 2021 22:59 UTC Amendment |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,808 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-046344 · doc4a.xml · derivative · entry 13 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,304 Underlying: Ordinary Shares · 8,808 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F1 · date: On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020. In fact, the shares vested monthly from June 3, 2020. F3 · derivative.exercise_date: On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years. F3 · derivative.expiration_date: On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years. Read SEC document |
| November 03, 2020 Filed Jul 12, 2021 22:59 UTC Amendment |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 8,808 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-046344 · doc4a.xml · nonDerivative · entry 6 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020. In fact, the shares vested monthly from June 3, 2020. F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| October 26, 2020 Filed Oct 28, 2020 18:12 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 208 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-056066 · doc4.xml · derivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,042 Underlying: Ordinary Shares · 208 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on January 26, 2019 representing 2,500 ordinary shares. 33.33% of the RSUs vested on January 26, 2020 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on January 26, 2019 representing 2,500 ordinary shares. 33.33% of the RSUs vested on January 26, 2020 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. Read SEC document |
| October 26, 2020 Filed Oct 28, 2020 18:12 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 101 | $20.95 | $2,115.56 |
DisclosureSEC source: 0001209191-20-056066 · doc4.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,343 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| October 26, 2020 Filed Oct 28, 2020 18:12 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 208 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-056066 · doc4.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| October 15, 2020 Filed Oct 16, 2020 19:41 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-055037 · doc4.xml · derivative · entry 7 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Ordinary Shares · 2,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F5 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 5,000 ordinary shares. Under the original terms of the agreement, 33.33% of the RSUs will vest on January 31, 2021 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. In September the award was modified to accelerate vesting at October 15, 2020 for amounts of RSUs that would have otherwise become vested as of April 15, 2021. F5 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 5,000 ordinary shares. Under the original terms of the agreement, 33.33% of the RSUs will vest on January 31, 2021 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. In September the award was modified to accelerate vesting at October 15, 2020 for amounts of RSUs that would have otherwise become vested as of April 15, 2021. Read SEC document |
| October 15, 2020 Filed Oct 16, 2020 19:41 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,084 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-055037 · doc4.xml · derivative · entry 6 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,082 Underlying: Ordinary Shares · 2,084 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F4 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on August 20, 2018 representing 5,000 ordinary shares. 33.33% of the RSUs vested on August 20, 2019 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. In September the award was modified to accelerate vesting at October 15, 2020 for amounts of RSUs that would have otherwise become vested as of April 15, 2021. F4 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on August 20, 2018 representing 5,000 ordinary shares. 33.33% of the RSUs vested on August 20, 2019 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. In September the award was modified to accelerate vesting at October 15, 2020 for amounts of RSUs that would have otherwise become vested as of April 15, 2021. Read SEC document |
| October 15, 2020 Filed Oct 16, 2020 19:41 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 833 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-055037 · doc4.xml · derivative · entry 5 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,667 Underlying: Ordinary Shares · 833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on January 26, 2019 representing 5,000 ordinary shares. 33.33% of the RSUs vested on January 26, 2020 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. In September the award was modified to accelerate vesting at October 15, 2020 for amounts of RSUs that would have otherwise become vested as of April 15, 2021. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on January 26, 2019 representing 5,000 ordinary shares. 33.33% of the RSUs vested on January 26, 2020 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. In September the award was modified to accelerate vesting at October 15, 2020 for amounts of RSUs that would have otherwise become vested as of April 15, 2021. Read SEC document |
| October 15, 2020 Filed Oct 16, 2020 19:41 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
SaleOrdinary Shares | 1,017 | $21.72 | $22,089.24 |
DisclosureSEC source: 0001209191-20-055037 · doc4.xml · nonDerivative · entry 4 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,405 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| October 15, 2020 Filed Oct 16, 2020 19:41 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
SaleOrdinary Shares | 407 | $21.82 | $8,882.49 |
DisclosureSEC source: 0001209191-20-055037 · doc4.xml · nonDerivative · entry 3 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,422 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| October 15, 2020 Filed Oct 16, 2020 19:41 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
SaleOrdinary Shares | 976 | $21.80 | $21,276.02 |
DisclosureSEC source: 0001209191-20-055037 · doc4.xml · nonDerivative · entry 2 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,829 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| October 15, 2020 Filed Oct 16, 2020 19:41 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
Exercise / conversionOrdinary Shares | 4,917 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-055037 · doc4.xml · nonDerivative · entry 1 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| October 03, 2020 Filed Jul 12, 2021 22:59 UTC Amendment |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,808 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-046344 · doc4a.xml · derivative · entry 12 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,112 Underlying: Ordinary Shares · 8,808 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F1 · date: On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020. In fact, the shares vested monthly from June 3, 2020. F3 · derivative.exercise_date: On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years. F3 · derivative.expiration_date: On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years. Read SEC document |
| October 03, 2020 Filed Jul 12, 2021 22:59 UTC Amendment |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 8,808 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-046344 · doc4a.xml · nonDerivative · entry 5 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020. In fact, the shares vested monthly from June 3, 2020. F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 20:37 UTC |
Henderson MollyChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-053641 · doc4.xml · derivative · entry 2 Henderson Molly · CIK 0001363812 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of October 1, 2021, October 1, 2022 and October 1, 2023. F3 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of October 1, 2021, October 1, 2022 and October 1, 2023. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 20:37 UTC |
Henderson MollyChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $19.66 | $0.00 |
DisclosureSEC source: 0001209191-20-053641 · doc4.xml · derivative · entry 1 Henderson Molly · CIK 0001363812 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2030-09-30 F1 · derivative.exercise_date: 1/3 of the shares underlying the stock options will vest on each of October 1, 2021, October 1, 2022 and October 1, 2023. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 20:35 UTC Amendment |
Smith Jason DrewGeneral Counsel
|
GrantRestricted Stock Unit · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-053632 · doc4a.xml · derivative · entry 2 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Ordinary Shares · 25,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. F1 · date: The stock options and restricted stock units represented on the original Form 4 were not granted to the reporting person until October 1, 2020, following approval by the Issuer's Compensation Committee on that date. F4 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of August 31, 2021, August 31, 2022 and August 31, 2023. F4 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of August 31, 2021, August 31, 2022 and August 31, 2023. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 20:35 UTC Amendment |
Smith Jason DrewGeneral Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $19.66 | $0.00 |
DisclosureSEC source: 0001209191-20-053632 · doc4a.xml · derivative · entry 1 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Ordinary Shares · 60,000 shares Expires 2030-09-30 F1 · date: The stock options and restricted stock units represented on the original Form 4 were not granted to the reporting person until October 1, 2020, following approval by the Issuer's Compensation Committee on that date. F2 · derivative.exercise_date: 1/3 of the shares underlying the stock option will vest on each of August 31, 2021, August 31, 2022 and August 31, 2023. Read SEC document |
| September 09, 2020 Filed Sep 10, 2020 16:14 UTC |
Smith Jason DrewGeneral Counsel
|
GrantRestricted Stock Unit · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-049937 · doc4.xml · derivative · entry 2 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Ordinary Shares · 25,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: 33.33% of the restricted stock units ("RSUs") will vest on September 9, 2021, 33.33% of the remaining RSUs will vest on September 9, 2022, and 33.34% of the remaining RSUs will vest on September 9, 2023. F3 · derivative.expiration_date: 33.33% of the restricted stock units ("RSUs") will vest on September 9, 2021, 33.33% of the remaining RSUs will vest on September 9, 2022, and 33.34% of the remaining RSUs will vest on September 9, 2023. Read SEC document |
| September 09, 2020 Filed Sep 10, 2020 16:14 UTC |
Smith Jason DrewGeneral Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $21.38 | $0.00 |
DisclosureSEC source: 0001209191-20-049937 · doc4.xml · derivative · entry 1 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Ordinary Shares · 60,000 shares Expires 2030-09-08 F1 · derivative.exercise_date: 33.33% of the shares underlying the stock option will vest on September 9, 2021, 33.33% of the remaining shares underlying the stock option will vest on September 9, 2022, and 33.34% of the remaining shares shares underlying the stock option will vest on September 9, 2023. Read SEC document |
| September 04, 2020 Filed Sep 8, 2020 20:48 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-049741 · doc4.xml · derivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,042 Underlying: Ordinary Shares · 1,041 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on December 7, 2017 representing 12,500 ordinary shares. 33.33% of the RSUs vested on December 4, 2018 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on December 7, 2017 representing 12,500 ordinary shares. 33.33% of the RSUs vested on December 4, 2018 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. Read SEC document |
| September 04, 2020 Filed Sep 8, 2020 20:48 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 348 | $20.20 | $7,029.60 |
DisclosureSEC source: 0001209191-20-049741 · doc4.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,236 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| September 04, 2020 Filed Sep 8, 2020 20:48 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 1,041 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-049741 · doc4.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| September 03, 2020 Filed Jul 12, 2021 22:59 UTC Amendment |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-046344 · doc4a.xml · derivative · entry 11 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,920 Underlying: Ordinary Shares · 8,807 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F1 · date: On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020. In fact, the shares vested monthly from June 3, 2020. F3 · derivative.exercise_date: On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years. F3 · derivative.expiration_date: On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years. Read SEC document |
| September 03, 2020 Filed Jul 12, 2021 22:59 UTC Amendment |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 8,807 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-046344 · doc4a.xml · nonDerivative · entry 4 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,693 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020. In fact, the shares vested monthly from June 3, 2020. F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| September 01, 2020 Filed Sep 1, 2020 18:37 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048883 · doc4.xml · derivative · entry 3 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,166 Underlying: Ordinary Shares · 1,042 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on August 20, 2018 representing 12,500 ordinary shares. 33.33% of the RSUs vested on August 20, 2019 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on August 20, 2018 representing 12,500 ordinary shares. 33.33% of the RSUs vested on August 20, 2019 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. Read SEC document |
| September 01, 2020 Filed Sep 1, 2020 18:37 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
SaleOrdinary Shares | 509 | $22.82 | $11,615.38 |
DisclosureSEC source: 0001209191-20-048883 · doc4.xml · nonDerivative · entry 2 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,888 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| September 01, 2020 Filed Sep 1, 2020 18:37 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
Exercise / conversionOrdinary Shares | 1,042 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-048883 · doc4.xml · nonDerivative · entry 1 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,397 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| August 03, 2020 Filed Jul 12, 2021 22:59 UTC Amendment |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-046344 · doc4a.xml · derivative · entry 10 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,727 Underlying: Ordinary Shares · 8,807 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F1 · date: On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020. In fact, the shares vested monthly from June 3, 2020. F3 · derivative.exercise_date: On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years. F3 · derivative.expiration_date: On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years. Read SEC document |
| August 03, 2020 Filed Jul 12, 2021 22:59 UTC Amendment |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 8,807 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-046344 · doc4a.xml · nonDerivative · entry 3 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,886 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020. In fact, the shares vested monthly from June 3, 2020. F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 21:32 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 70 | $23.51 | $1,645.70 |
DisclosureSEC source: 0001209191-20-043873 · doc4.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,543 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 21:34 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
SaleOrdinary Shares | 141 | $23.51 | $3,314.91 |
DisclosureSEC source: 0001209191-20-043874 · doc4.xml · nonDerivative · entry 2 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,355 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| July 26, 2020 Filed Jul 28, 2020 21:32 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 209 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-043873 · doc4.xml · derivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Underlying: Ordinary Shares · 209 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on January 26, 2019 representing 2,500 ordinary shares. 33.33% of the RSUs vested on January 26, 2020 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on January 26, 2019 representing 2,500 ordinary shares. 33.33% of the RSUs vested on January 26, 2020 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. Read SEC document |
| July 26, 2020 Filed Jul 28, 2020 21:32 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 209 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-043873 · doc4.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,613 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| July 26, 2020 Filed Jul 28, 2020 21:34 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 417 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-043874 · doc4.xml · derivative · entry 3 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Ordinary Shares · 417 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on January 26, 2019 representing 5,000 ordinary shares. 33.33% of the RSUs vested on January 26, 2020 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on January 26, 2019 representing 5,000 ordinary shares. 33.33% of the RSUs vested on January 26, 2020 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. Read SEC document |
| July 26, 2020 Filed Jul 28, 2020 21:34 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
Exercise / conversionOrdinary Shares | 417 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-043874 · doc4.xml · nonDerivative · entry 1 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,496 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| July 03, 2020 Filed Jul 12, 2021 22:59 UTC Amendment |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-046344 · doc4a.xml · derivative · entry 9 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,534 Underlying: Ordinary Shares · 8,807 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F1 · date: On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020. In fact, the shares vested monthly from June 3, 2020. F3 · derivative.exercise_date: On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years. F3 · derivative.expiration_date: On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years. Read SEC document |
| July 03, 2020 Filed Jul 12, 2021 22:59 UTC Amendment |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 8,807 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-046344 · doc4a.xml · nonDerivative · entry 2 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020. In fact, the shares vested monthly from June 3, 2020. F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 18:40 UTC |
Holden StuartDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $28.24 | $0.00 |
DisclosureSEC source: 0001209191-20-035680 · doc4.xml · derivative · entry 1 Holden Stuart · CIK 0001763999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2030-06-07 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 22:43 UTC |
Tomasello ShawnDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $28.24 | $0.00 |
DisclosureSEC source: 0001209191-20-035684 · doc4.xml · derivative · entry 1 Tomasello Shawn · CIK 0001617239 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2030-06-07 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 22:41 UTC |
Nussbaum RanDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $28.24 | $0.00 |
DisclosureSEC source: 0001209191-20-035682 · doc4.xml · derivative · entry 1 Nussbaum Ran · CIK 0001609805 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2030-06-07 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 22:39 UTC |
FALBERG KATHRYN EDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $28.24 | $0.00 |
DisclosureSEC source: 0001209191-20-035679 · doc4.xml · derivative · entry 1 FALBERG KATHRYN E · CIK 0001206977 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2030-06-07 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.